Principal Financial Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.1K | Sell |
12,160
-1,829
| -13% | -$4.23K | ﹤0.01% | 2205 |
|
2025
Q1 | $19.4K | Sell |
13,989
-982
| -7% | -$1.37K | ﹤0.01% | 2148 |
|
2024
Q4 | $25.9K | Sell |
14,971
-828
| -5% | -$1.43K | ﹤0.01% | 2192 |
|
2024
Q3 | $31.8K | Sell |
15,799
-5,810
| -27% | -$11.7K | ﹤0.01% | 2196 |
|
2024
Q2 | $48.4K | Buy |
+21,609
| New | +$48.4K | ﹤0.01% | 2287 |
|